Nautilus Biotechnology, Inc. (NAUT)
2.25
+0.43
(+23.63%)
USD |
NASDAQ |
Oct 09, 16:00
2.25
0.00 (0.00%)
After-Hours: 20:00
Nautilus Biotechnology Total Assets (Quarterly) : 163.58M for June 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 163.58M |
| March 31, 2026 | 177.78M |
| December 31, 2025 | 191.11M |
| September 30, 2025 | 200.92M |
| June 30, 2025 | 213.19M |
| March 31, 2025 | 227.69M |
| December 31, 2024 | 242.74M |
| September 30, 2024 | 259.70M |
| June 30, 2024 | 272.75M |
| March 31, 2024 | 288.65M |
| December 31, 2023 | 305.56M |
| September 30, 2023 | 318.34M |
| June 30, 2023 | 330.77M |
| Date | Value |
|---|---|
| March 31, 2023 | 345.88M |
| December 31, 2022 | 350.05M |
| September 30, 2022 | 359.31M |
| June 30, 2022 | 371.71M |
| March 31, 2022 | 384.67M |
| December 31, 2021 | 398.45M |
| September 30, 2021 | 385.35M |
| June 30, 2021 | 393.28M |
| March 31, 2021 | 150.50M |
| December 31, 2020 | 85.01M |
| September 30, 2020 | 150.95M |
| June 30, 2020 | 0.2113M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 13.97B |
| Bio-Rad Laboratories, Inc. | 10.25B |
| Bruker Corp. | 6.053B |
| Danaher Corp. | 92.37B |
| Harvard Bioscience, Inc. | 76.29M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 32.46M |
| Shareholders Equity (Quarterly) | 131.11M |
| Debt to Equity Ratio | 0.2122 |
| Current Ratio | 10.14 |
| Net Debt Paydown Yield | 0.13% |